Address
Email address
Phone number
Website
https://www.meditsiinigrupp.eeMeditsiinigrupp AS - Meditsiinitehnika müük ja hooldusAS Meditsiinigrupp toob maale, müüb ja hooldab erinevaid meditsiiniseadmeid tunnustatud tootjatelt Philips Medical Systems, Abbott Laboratories, Laerdal jpt.
Name
AKTSIASELTS MEDITSIINIGRUPP
Registry code
10195499
VAT number
EE100668928
Type
AS - Joint Stock Company
Status
Registered
Foundation date
17.02.1997 (27)
Financial year
01.01-31.12
Capital
25 560.00 €
Activity
46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Genoviir OÜ 10885436 | 100% - 25 560.00 EUR | - | - | Shareholder |
| Toomas Värton 27.04.1971 (53) | - | Board member | More than 50% ownership in the consolidated entity's voting rights | |
| Sirje Värton 19.07.1973 (51) | - | - | - | Board member |
| Villu Valgi 06.07.1957 (67) | - | - | - | Board member |
| Kristjan Värton 04.04.1974 (50) | - | - | - | Chairman of the board |
| Silvi Sild 29.06.1950 (74) | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Nanoviir OÜ 14122793 | - | - | - | Founder |
| Medoviir OÜ 12364055 | - | - | - | Founder |
| 2019 13.10.2020 | 2020 25.06.2021 | 2021 13.10.2022 | 2022 13.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 6 870 534 € | 10 697 410 € | 8 272 237 € | 10 601 460 € |
| Net profit (loss) for the period | 61 412 € | 946 373 € | 958 096 € | 1 438 235 € |
| Profit Margin | 1% | 9% | 12% | 14% |
| Current Assets | 4 572 076 € | 4 031 771 € | 6 793 938 € | 6 651 134 € |
| Fixed Assets | 7 827 € | 9 467 € | 228 229 € | 67 492 € |
| Total Assets | 4 579 903 € | 4 041 238 € | 7 022 167 € | 6 718 626 € |
| Current Liabilities | 3 076 831 € | 1 281 791 € | 3 434 624 € | 1 777 817 € |
| Non Current Liabilities | 340 000 € | 650 000 € | 520 000 € | 435 031 € |
| Total Liabilities | 3 416 831 € | 1 931 791 € | 3 954 624 € | 2 212 848 € |
| Share Capital | 25 560 € | 25 560 € | 25 560 € | 25 560 € |
| Equity | 1 163 072 € | 2 109 447 € | 3 067 543 € | 4 505 778 € |
| Employees | 18 | 17 | 17 | 17 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 2 489 064.71 € | 346 318.32 € | 89 682.15 € | 19 |
| 2023 Q4 | 2 812 254.81 € | 325 868.72 € | 77 356.71 € | 20 |
| 2023 Q3 | 2 324 677.01 € | 263 659.89 € | 76 799.53 € | 18 |
| 2023 Q2 | 3 124 460.85 € | 352 033.04 € | 69 779.38 € | 18 |
| 2023 Q1 | 3 241 895.55 € | 370 985.35 € | 66 465.6 € | 17 |
| 2022 Q4 | 3 788 466.78 € | 436 829.68 € | 63 810.86 € | 18 |
| 2022 Q3 | 2 478 536.02 € | 279 766.69 € | 61 218.17 € | 17 |
| 2022 Q2 | 3 892 509.31 € | 479 953.23 € | 61 859.59 € | 17 |
| 2022 Q1 | 4 559 468.56 € | 596 616.5 € | 64 969.84 € | 17 |
| 2021 Q4 | 4 554 188.42 € | 506 467.35 € | 57 251.71 € | 17 |
| 2021 Q3 | 2 564 875.6 € | 161 312.58 € | 58 803.23 € | 18 |
| 2021 Q2 | 2 018 777.12 € | 232 063.17 € | 70 337.36 € | 17 |
| 2021 Q1 | 2 490 827.74 € | 311 461.56 € | 61 638.63 € | 19 |
| 2020 Q4 | 3 809 817.23 € | 436 456.24 € | 59 273.21 € | 18 |
| 2020 Q3 | 2 742 042.81 € | 407 778.04 € | 63 127.78 € | 19 |
| 2020 Q2 | 4 755 567.38 € | 596 566.74 € | 64 726.86 € | 19 |
| 2020 Q1 | 2 322 697.51 € | 299 267.51 € | 60 245.5 € | 20 |
